Swiss National Bank
GTHX

Swiss National Bank’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Swiss National Bank’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-92,600
Closed -$248K – 2671
2023
Q1 		$248K Sell
92,600
-10,900
-11% -$52.4K ﹤0.01% 2627
2022
Q4 		$562K Buy
+103,500
New +$867K ﹤0.01% 2545
2022
Q2 		– Sell
-70,400
Closed -$535K – 2804
2022
Q1 		$535K Buy
70,400
+5,900
+9% +$56K ﹤0.01% 2590
2021
Q4 		$659K Hold
64,500
– – ﹤0.01% 2601
2021
Q3 		$866K Hold
64,500
– – ﹤0.01% 2475
2021
Q2 		$1.42M Hold
64,500
– – ﹤0.01% 2310
2021
Q1 		$1.55M Hold
64,500
– – ﹤0.01% 2151
2020
Q4 		$1.16M Buy
64,500
+1,400
+2% +$20.9K ﹤0.01% 2221
2020
Q3 		$729K Hold
63,100
– – ﹤0.01% 2250
2020
Q2 		$1.53M Buy
63,100
+12,100
+24% +$200K ﹤0.01% 1860
2020
Q1 		$562K Buy
51,000
+800
+2% +$14.9K ﹤0.01% 2131
2019
Q4 		$1.33M Buy
50,200
+1,100
+2% +$25.7K ﹤0.01% 1973
2019
Q3 		$1.12M Buy
49,100
+700
+1% +$22.1K ﹤0.01% 2001
2019
Q2 		$1.48M Buy
48,400
+4,300
+10% +$90.5K ﹤0.01% 1885
2019
Q1 		$732K Buy
44,100
+5,700
+15% +$108K ﹤0.01% 2239
2018
Q4 		$735K Buy
38,400
+1,300
+4% +$48.7K ﹤0.01% 2174
2018
Q3 		$1.94M Buy
37,100
+1,600
+5% +$87.2K ﹤0.01% 1738
2018
Q2 		$1.54M Hold
35,500
– – ﹤0.01% 1889
2018
Q1 		$1.31M Buy
35,500
+21,100
+147% +$563K ﹤0.01% 1916
2017
Q4 		$286K Buy
+14,400
New +$310K ﹤0.01% 2494

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's GTHX Position: Q2 2023 in Review

Swiss National Bank sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2023, closing a stake of 92,600 shares — an estimated $248K sold.

Swiss National Bank first reported a position in GTHX in Q4 2017 and held it in 20 quarters. The position peaked at $1.94M in Q3 2018. 80 funds tracked by Wall St. Rank hold GTHX as of Q2 2023.

  • Swiss National Bank reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 92,600 G1 Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $248K.
  • Swiss National Bank first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • Swiss National Bank's G1 Therapeutics, Inc. Common Stock position peaked at $1.94M in Q3 2018.
  • 80 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.